Separately, the Business Group on Health reported that 10% of companies currently covering GLP-1s for weight management say they are unlikely to continue in 2027 for cost reasons
Participants lost 16.7% of baseline weight over 64 weeks, matching clinical trial outcomes despite using half the typical drug dose
Currently all of our packaging is FDA certified food safe and 100% recyclable
Furthermore, recovery of BDNF levels results in the improvement of neuroplasticity and reduction of neuronal apoptosis (Kraus et al., 2017)
New, more effective molecules with optimized pharmacokinetics produce greater weight loss and some may be more effective for various metabolic disorders, through incorporation of one or more additional peptide epitopes
In some brain regions, GLP-1 receptor activation triggers both effects, but in others, like the hippocampus or the ventral tegmental area, food intake reduction occurs without nausea